Eyepoint Pharmaceuticals Inc (EYPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EYPT | UPB | CERT | ||
| Company | Eyepoint Pharmaceuticals Inc | Upstream Bio Inc | Certara Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 16.86 | 27.82 | 9.56 | ||
| High | 17.82 | 28.42 | 9.61 | ||
| Low | 16.59 | 27.00 | 9.14 | ||
| Latest | 17.74 | 27.75 | 9.22 | ||
| Change | +1.02 | +0.01 | -0.35 | ||
| % Change | +6.10% | +0.04% | -3.66% | ||
| Volume | 1,463,000 | 399,800 | 1,761,000 | ||
| 20-Day Average Volume | 1,118,875 | 516,180 | 2,811,755 | ||
| Previous Close | 16.72 | 27.74 | 9.57 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 13.68 | 25.82 | 8.75 | ||
| 20-Day Raw Stochastic | 98.94% | 52.36% | 38.67% | ||
| 20-Day Relative Strength | 70.34 | 59.93 | 43.46 | ||
| Weighted Alpha | +135.40 | +91.36 | -23.96 | ||
| Today's Opinion | 100% Buy | 100% Buy | 72% Sell | ||
| Previous Opinion | 100% Buy | 100% Buy | 72% Sell | ||
| Last Month's Opinion | 24% Buy | 100% Buy | 16% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +19.62% since 11/28/25 | -2.97% since 11/28/25 | +0.66% since 11/28/25 | ||
| Low | 13.61 on 12/02/25 | 24.61 on 12/02/25 | 8.75 on 12/01/25 | ||
| High | 17.82 on 12/05/25 | 29.89 on 12/02/25 | 9.72 on 12/04/25 | ||
| 1-Month | |||||
| %Chg | +60.98% since 11/05/25 | +15.77% since 11/05/25 | -20.31% since 11/05/25 | ||
| Low | 10.28 on 11/07/25 | 21.98 on 11/07/25 | 8.02 on 11/20/25 | ||
| High | 17.82 on 12/05/25 | 33.00 on 11/26/25 | 11.71 on 11/06/25 | ||
| 3-Month | |||||
| %Chg | +26.62% since 09/05/25 | +38.96% since 09/05/25 | -12.36% since 09/05/25 | ||
| Low | 9.65 on 11/05/25 | 15.55 on 09/17/25 | 8.02 on 11/20/25 | ||
| High | 17.82 on 12/05/25 | 33.00 on 11/26/25 | 13.88 on 10/03/25 | ||
| 6-Month | |||||
| %Chg | +115.03% since 06/05/25 | +156.23% since 06/05/25 | -21.20% since 06/05/25 | ||
| Low | 7.94 on 06/23/25 | 9.82 on 06/18/25 | 8.02 on 11/20/25 | ||
| High | 17.82 on 12/05/25 | 33.00 on 11/26/25 | 13.88 on 10/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,468,641 | 1,499,582 | 1,468,497 | ||
| Shares Outstanding, K | 82,787 | 54,039 | 159,273 | ||
| Annual Sales | 43,270,000 | 2,370,000 | 385,150,000 | ||
| Annual Net Income | -130,870,000 | -62,810,000 | -12,050,000 | ||
| Last Quarter Sales | 970,000 | 680,000 | 104,620,000 | ||
| Last Quarter Net Income | -59,730,000 | -33,750,000 | 1,530,000 | ||
| 60-Month Beta | 1.67 | 1.83 | 1.46 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.85 on 11/05/25 | -0.63 on 11/05/25 | 0.14 on 11/06/25 | ||
| Latest Earnings Date | 11/05/25 | 11/06/25 | 11/06/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 28.15 | ||